Bacterial resistance is still a major concern in antibiotic therapy, especially for immunocompromised and transplantation patients. New therapeutic options are, therefore, needed to overcome the onset of antibiotic resistance. This article reviews the potential role of some antibiotics recently marketed or in clinical development, with a focus on their potential use in transplant recipients.